AlphaStocks
5.5
Consider Buy

Viatris Inc (VTRS)

Health Care / Pharmaceuticals

S&P 500

$15.96

Middle of the pack. No strong signal either way.

Consider Buy

Score based on 2 of 5 models — limited data

#415out of 1126 in Health Care

Is Viatris Inc a Good Investment in 2026?

Viatris Inc (VTRS) scores 5.5 out of 10 on AlphaStocks' composite model, earning a Consider Buy rating. The Lynch model rates Viatris Inc as Attractive. However, the Buffett model rates it Caution. Viatris Inc currently trades below its estimated fair value of $19, suggesting potential upside. Viatris Inc ranks #415 out of 1126 stocks in the Health Care sector.

This summary is algorithmically generated and is not financial advice.

Key Metrics

ROE114.4Market Cap19B

Estimated Fair Value

$19.0516% below

Fair value above market price — fundamentals support a higher valuation.

Model-based estimate, not a price target.

5-Model Analysis

Each model evaluates this stock from a different angle. Combined, they form the composite score above.

Piotroski

Neutral

3/9

Buffett

Caution

Business quality & competitive moat

Graham

Limited Data

Price vs intrinsic value

Lynch

Attractive

Growth rate vs price (PEG)

Greenblatt

Limited Data

Earnings yield + return on capital

Frequently Asked Questions

Is Viatris Inc (VTRS) a good investment?
Based on AlphaStocks' composite analysis, Viatris Inc (VTRS) scores 5.5 out of 10, earning a Consider Buy rating. This is a middle-of-the-pack score with no strong signal either way. Fair value above market price — fundamentals support a higher valuation.
What is Viatris Inc's Piotroski F-Score?
Viatris Inc's Piotroski F-Score status is Neutral. The raw score is 3/9. The Piotroski F-Score evaluates financial health using 9 fundamental signals including profitability, leverage, and operating efficiency.
Is VTRS overvalued or undervalued?
Based on AlphaStocks' model-based fair value estimate of $19, VTRS appears undervalued. The stock currently trades 16% below its estimated fair value. Fair value above market price — fundamentals support a higher valuation.
How does VTRS compare to other Health Care stocks?
Viatris Inc ranks #415 out of 1126 stocks in the Health Care sector, placing it in the top 37% of its sector by composite score. This is an above-average position relative to sector peers.
What do investment models say about VTRS?
AlphaStocks evaluates VTRS using five proven investment models. Piotroski: Neutral; Buffett: Caution; Lynch: Attractive. These models are combined into a single composite score of 5.5/10.

Similar Stocks

PARRAZNFTI

Compare VTRS with

VTRS vs PARRVTRS vs AZNVTRS vs FTI

Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer